Dapaalfa 5mg Tablet
Marketer
Alphard Pharmaceuticals Private Limited
Salt Composition
Dapagliflozin (5mg)
Overview Dapaalfa 5mg Tablet
Glucoreg 5mg tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes mellitus. This medication effectively lowers elevated blood glucose, mitigating the risk of serious diabetic complications and contributing to cardiovascular protection. Glucoreg 5mg can be administered with or without food, consistently at the same time each day, as directed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may lead to hyperglycemia and increased risk of severe consequences such as renal impairment and vision loss. Optimal treatment encompasses this medication alongside a doctor-recommended regimen including a balanced diet, regular physical activity, and weight management. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections. Excessive fluid loss is possible; ensure adequate hydration to prevent dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Dapaalfa 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Dapaalfa 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapaalfa 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Dapaalfa tablet whole; avoid crushing, chewing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Dapaalfa 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaalfa 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 5mg Dapaalfa tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Dapaalfa 5mg Tablet works:
Dapaalfa 5mg tablets are used to manage diabetes. Their mechanism of action involves the urinary excretion of excess glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dapaalfa 5mg Tablet is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Dapaalfa 5mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Dapaalfa 5mg tablets are likely incompatible. Available data from human studies indicate potential transfer of the drug into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Dapaalfa 5mg Tablets due to potential safety risks. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapaalfa 5mg tablets may be administered to patients with hepatic impairment without modification of the dosage regimen.
What if you forget to take Dapaalfa 5mg Tablet :
Should you forget a Dapaalfa 5mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapaalfa 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently